SummitTX Capital’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-42,066
Closed -$567K 1018
2025
Q1
$567K Buy
+42,066
New +$567K 0.02% 514